Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Adult and Pediatric Vaccines Market Growth (Status and Outlook) 2022-2028

  • LP 4798954
  • 101 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Adult and Pediatric Vaccines will have significant change from previous year. According to our (LP Information) latest study, the global Adult and Pediatric Vaccines market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Adult and Pediatric Vaccines market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Adult and Pediatric Vaccines market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Adult and Pediatric Vaccines market, reaching US$ million by the year 2028. As for the Europe Adult and Pediatric Vaccines landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Adult and Pediatric Vaccines players cover GlaxoSmithKline, Sanofi, Merck, and Novartis, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Adult and Pediatric Vaccines market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

Adult Vaccines

Pediatric Vaccines

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Hospitals

Medical Care Centers

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

GlaxoSmithKline

Sanofi

Merck

Novartis

Pfizer

AstraZeneca

Johnson and Johnson

Takeda Pharmaceutical

Bavarian Nordic

LG Life Sciences

Sinovac Biotech

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Adult and Pediatric Vaccines Market Size 2017-2028

2.1.2 Adult and Pediatric Vaccines Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Adult and Pediatric Vaccines Segment by Type

2.2.1 Adult Vaccines

2.2.2 Pediatric Vaccines

2.3 Adult and Pediatric Vaccines Market Size by Type

2.3.1 Adult and Pediatric Vaccines Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Adult and Pediatric Vaccines Market Size Market Share by Type (2017-2022)

2.4 Adult and Pediatric Vaccines Segment by Application

2.4.1 Hospitals

2.4.2 Medical Care Centers

2.4.3 Others

2.5 Adult and Pediatric Vaccines Market Size by Application

2.5.1 Adult and Pediatric Vaccines Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Adult and Pediatric Vaccines Market Size Market Share by Application (2017-2022)

3 Adult and Pediatric Vaccines Market Size by Player

3.1 Adult and Pediatric Vaccines Market Size Market Share by Players

3.1.1 Global Adult and Pediatric Vaccines Revenue by Players (2020-2022)

3.1.2 Global Adult and Pediatric Vaccines Revenue Market Share by Players (2020-2022)

3.2 Global Adult and Pediatric Vaccines Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Adult and Pediatric Vaccines by Regions

4.1 Adult and Pediatric Vaccines Market Size by Regions (2017-2022)

4.2 Americas Adult and Pediatric Vaccines Market Size Growth (2017-2022)

4.3 APAC Adult and Pediatric Vaccines Market Size Growth (2017-2022)

4.4 Europe Adult and Pediatric Vaccines Market Size Growth (2017-2022)

4.5 Middle East & Africa Adult and Pediatric Vaccines Market Size Growth (2017-2022)

5 Americas

5.1 Americas Adult and Pediatric Vaccines Market Size by Country (2017-2022)

5.2 Americas Adult and Pediatric Vaccines Market Size by Type (2017-2022)

5.3 Americas Adult and Pediatric Vaccines Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Adult and Pediatric Vaccines Market Size by Region (2017-2022)

6.2 APAC Adult and Pediatric Vaccines Market Size by Type (2017-2022)

6.3 APAC Adult and Pediatric Vaccines Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Adult and Pediatric Vaccines by Country (2017-2022)

7.2 Europe Adult and Pediatric Vaccines Market Size by Type (2017-2022)

7.3 Europe Adult and Pediatric Vaccines Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Adult and Pediatric Vaccines by Region (2017-2022)

8.2 Middle East & Africa Adult and Pediatric Vaccines Market Size by Type (2017-2022)

8.3 Middle East & Africa Adult and Pediatric Vaccines Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Adult and Pediatric Vaccines Market Forecast

10.1 Global Adult and Pediatric Vaccines Forecast by Regions (2023-2028)

10.1.1 Global Adult and Pediatric Vaccines Forecast by Regions (2023-2028)

10.1.2 Americas Adult and Pediatric Vaccines Forecast

10.1.3 APAC Adult and Pediatric Vaccines Forecast

10.1.4 Europe Adult and Pediatric Vaccines Forecast

10.1.5 Middle East & Africa Adult and Pediatric Vaccines Forecast

10.2 Americas Adult and Pediatric Vaccines Forecast by Country (2023-2028)

10.2.1 United States Adult and Pediatric Vaccines Market Forecast

10.2.2 Canada Adult and Pediatric Vaccines Market Forecast

10.2.3 Mexico Adult and Pediatric Vaccines Market Forecast

10.2.4 Brazil Adult and Pediatric Vaccines Market Forecast

10.3 APAC Adult and Pediatric Vaccines Forecast by Region (2023-2028)

10.3.1 China Adult and Pediatric Vaccines Market Forecast

10.3.2 Japan Adult and Pediatric Vaccines Market Forecast

10.3.3 Korea Adult and Pediatric Vaccines Market Forecast

10.3.4 Southeast Asia Adult and Pediatric Vaccines Market Forecast

10.3.5 India Adult and Pediatric Vaccines Market Forecast

10.3.6 Australia Adult and Pediatric Vaccines Market Forecast

10.4 Europe Adult and Pediatric Vaccines Forecast by Country (2023-2028)

10.4.1 Germany Adult and Pediatric Vaccines Market Forecast

10.4.2 France Adult and Pediatric Vaccines Market Forecast

10.4.3 UK Adult and Pediatric Vaccines Market Forecast

10.4.4 Italy Adult and Pediatric Vaccines Market Forecast

10.4.5 Russia Adult and Pediatric Vaccines Market Forecast

10.5 Middle East & Africa Adult and Pediatric Vaccines Forecast by Region (2023-2028)

10.5.1 Egypt Adult and Pediatric Vaccines Market Forecast

10.5.2 South Africa Adult and Pediatric Vaccines Market Forecast

10.5.3 Israel Adult and Pediatric Vaccines Market Forecast

10.5.4 Turkey Adult and Pediatric Vaccines Market Forecast

10.5.5 GCC Countries Adult and Pediatric Vaccines Market Forecast

10.6 Global Adult and Pediatric Vaccines Forecast by Type (2023-2028)

10.7 Global Adult and Pediatric Vaccines Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 GlaxoSmithKline

11.1.1 GlaxoSmithKline Company Information

11.1.2 GlaxoSmithKline Adult and Pediatric Vaccines Product Offered

11.1.3 GlaxoSmithKline Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 GlaxoSmithKline Main Business Overview

11.1.5 GlaxoSmithKline Latest Developments

11.2 Sanofi

11.2.1 Sanofi Company Information

11.2.2 Sanofi Adult and Pediatric Vaccines Product Offered

11.2.3 Sanofi Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Sanofi Main Business Overview

11.2.5 Sanofi Latest Developments

11.3 Merck

11.3.1 Merck Company Information

11.3.2 Merck Adult and Pediatric Vaccines Product Offered

11.3.3 Merck Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Merck Main Business Overview

11.3.5 Merck Latest Developments

11.4 Novartis

11.4.1 Novartis Company Information

11.4.2 Novartis Adult and Pediatric Vaccines Product Offered

11.4.3 Novartis Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Novartis Main Business Overview

11.4.5 Novartis Latest Developments

11.5 Pfizer

11.5.1 Pfizer Company Information

11.5.2 Pfizer Adult and Pediatric Vaccines Product Offered

11.5.3 Pfizer Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Pfizer Main Business Overview

11.5.5 Pfizer Latest Developments

11.6 AstraZeneca

11.6.1 AstraZeneca Company Information

11.6.2 AstraZeneca Adult and Pediatric Vaccines Product Offered

11.6.3 AstraZeneca Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 AstraZeneca Main Business Overview

11.6.5 AstraZeneca Latest Developments

11.7 Johnson and Johnson

11.7.1 Johnson and Johnson Company Information

11.7.2 Johnson and Johnson Adult and Pediatric Vaccines Product Offered

11.7.3 Johnson and Johnson Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Johnson and Johnson Main Business Overview

11.7.5 Johnson and Johnson Latest Developments

11.8 Takeda Pharmaceutical

11.8.1 Takeda Pharmaceutical Company Information

11.8.2 Takeda Pharmaceutical Adult and Pediatric Vaccines Product Offered

11.8.3 Takeda Pharmaceutical Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Takeda Pharmaceutical Main Business Overview

11.8.5 Takeda Pharmaceutical Latest Developments

11.9 Bavarian Nordic

11.9.1 Bavarian Nordic Company Information

11.9.2 Bavarian Nordic Adult and Pediatric Vaccines Product Offered

11.9.3 Bavarian Nordic Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Bavarian Nordic Main Business Overview

11.9.5 Bavarian Nordic Latest Developments

11.10 LG Life Sciences

11.10.1 LG Life Sciences Company Information

11.10.2 LG Life Sciences Adult and Pediatric Vaccines Product Offered

11.10.3 LG Life Sciences Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 LG Life Sciences Main Business Overview

11.10.5 LG Life Sciences Latest Developments

11.11 Sinovac Biotech

11.11.1 Sinovac Biotech Company Information

11.11.2 Sinovac Biotech Adult and Pediatric Vaccines Product Offered

11.11.3 Sinovac Biotech Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Sinovac Biotech Main Business Overview

11.11.5 Sinovac Biotech Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Adult and Pediatric Vaccines Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Adult Vaccines

Table 3. Major Players of Pediatric Vaccines

Table 4. Adult and Pediatric Vaccines Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 5. Global Adult and Pediatric Vaccines Market Size by Type (2017-2022) & ($ Millions)

Table 6. Global Adult and Pediatric Vaccines Market Size Market Share by Type (2017-2022)

Table 7. Adult and Pediatric Vaccines Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Adult and Pediatric Vaccines Market Size by Application (2017-2022) & ($ Millions)

Table 9. Global Adult and Pediatric Vaccines Market Size Market Share by Application (2017-2022)

Table 10. Global Adult and Pediatric Vaccines Revenue by Players (2020-2022) & ($ Millions)

Table 11. Global Adult and Pediatric Vaccines Revenue Market Share by Player (2020-2022)

Table 12. Adult and Pediatric Vaccines Key Players Head office and Products Offered

Table 13. Adult and Pediatric Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 14. New Products and Potential Entrants

Table 15. Mergers & Acquisitions, Expansion

Table 16. Global Adult and Pediatric Vaccines Market Size by Regions 2017-2022 & ($ Millions)

Table 17. Global Adult and Pediatric Vaccines Market Size Market Share by Regions (2017-2022)

Table 18. Americas Adult and Pediatric Vaccines Market Size by Country (2017-2022) & ($ Millions)

Table 19. Americas Adult and Pediatric Vaccines Market Size Market Share by Country (2017-2022)

Table 20. Americas Adult and Pediatric Vaccines Market Size by Type (2017-2022) & ($ Millions)

Table 21. Americas Adult and Pediatric Vaccines Market Size Market Share by Type (2017-2022)

Table 22. Americas Adult and Pediatric Vaccines Market Size by Application (2017-2022) & ($ Millions)

Table 23. Americas Adult and Pediatric Vaccines Market Size Market Share by Application (2017-2022)

Table 24. APAC Adult and Pediatric Vaccines Market Size by Region (2017-2022) & ($ Millions)

Table 25. APAC Adult and Pediatric Vaccines Market Size Market Share by Region (2017-2022)

Table 26. APAC Adult and Pediatric Vaccines Market Size by Type (2017-2022) & ($ Millions)

Table 27. APAC Adult and Pediatric Vaccines Market Size Market Share by Type (2017-2022)

Table 28. APAC Adult and Pediatric Vaccines Market Size by Application (2017-2022) & ($ Millions)

Table 29. APAC Adult and Pediatric Vaccines Market Size Market Share by Application (2017-2022)

Table 30. Europe Adult and Pediatric Vaccines Market Size by Country (2017-2022) & ($ Millions)

Table 31. Europe Adult and Pediatric Vaccines Market Size Market Share by Country (2017-2022)

Table 32. Europe Adult and Pediatric Vaccines Market Size by Type (2017-2022) & ($ Millions)

Table 33. Europe Adult and Pediatric Vaccines Market Size Market Share by Type (2017-2022)

Table 34. Europe Adult and Pediatric Vaccines Market Size by Application (2017-2022) & ($ Millions)

Table 35. Europe Adult and Pediatric Vaccines Market Size Market Share by Application (2017-2022)

Table 36. Middle East & Africa Adult and Pediatric Vaccines Market Size by Region (2017-2022) & ($ Millions)

Table 37. Middle East & Africa Adult and Pediatric Vaccines Market Size Market Share by Region (2017-2022)

Table 38. Middle East & Africa Adult and Pediatric Vaccines Market Size by Type (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Adult and Pediatric Vaccines Market Size Market Share by Type (2017-2022)

Table 40. Middle East & Africa Adult and Pediatric Vaccines Market Size by Application (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Adult and Pediatric Vaccines Market Size Market Share by Application (2017-2022)

Table 42. Key Market Drivers & Growth Opportunities of Adult and Pediatric Vaccines

Table 43. Key Market Challenges & Risks of Adult and Pediatric Vaccines

Table 44. Key Industry Trends of Adult and Pediatric Vaccines

Table 45. Global Adult and Pediatric Vaccines Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 46. Global Adult and Pediatric Vaccines Market Size Market Share Forecast by Regions (2023-2028)

Table 47. Global Adult and Pediatric Vaccines Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 48. Global Adult and Pediatric Vaccines Market Size Market Share Forecast by Type (2023-2028)

Table 49. Global Adult and Pediatric Vaccines Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 50. Global Adult and Pediatric Vaccines Market Size Market Share Forecast by Application (2023-2028)

Table 51. GlaxoSmithKline Details, Company Type, Adult and Pediatric Vaccines Area Served and Its Competitors

Table 52. GlaxoSmithKline Adult and Pediatric Vaccines Product Offered

Table 53. GlaxoSmithKline Adult and Pediatric Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 54. GlaxoSmithKline Main Business

Table 55. GlaxoSmithKline Latest Developments

Table 56. Sanofi Details, Company Type, Adult and Pediatric Vaccines Area Served and Its Competitors

Table 57. Sanofi Adult and Pediatric Vaccines Product Offered

Table 58. Sanofi Main Business

Table 59. Sanofi Adult and Pediatric Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 60. Sanofi Latest Developments

Table 61. Merck Details, Company Type, Adult and Pediatric Vaccines Area Served and Its Competitors

Table 62. Merck Adult and Pediatric Vaccines Product Offered

Table 63. Merck Main Business

Table 64. Merck Adult and Pediatric Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 65. Merck Latest Developments

Table 66. Novartis Details, Company Type, Adult and Pediatric Vaccines Area Served and Its Competitors

Table 67. Novartis Adult and Pediatric Vaccines Product Offered

Table 68. Novartis Main Business

Table 69. Novartis Adult and Pediatric Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 70. Novartis Latest Developments

Table 71. Pfizer Details, Company Type, Adult and Pediatric Vaccines Area Served and Its Competitors

Table 72. Pfizer Adult and Pediatric Vaccines Product Offered

Table 73. Pfizer Main Business

Table 74. Pfizer Adult and Pediatric Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 75. Pfizer Latest Developments

Table 76. AstraZeneca Details, Company Type, Adult and Pediatric Vaccines Area Served and Its Competitors

Table 77. AstraZeneca Adult and Pediatric Vaccines Product Offered

Table 78. AstraZeneca Main Business

Table 79. AstraZeneca Adult and Pediatric Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 80. AstraZeneca Latest Developments

Table 81. Johnson and Johnson Details, Company Type, Adult and Pediatric Vaccines Area Served and Its Competitors

Table 82. Johnson and Johnson Adult and Pediatric Vaccines Product Offered

Table 83. Johnson and Johnson Main Business

Table 84. Johnson and Johnson Adult and Pediatric Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 85. Johnson and Johnson Latest Developments

Table 86. Takeda Pharmaceutical Details, Company Type, Adult and Pediatric Vaccines Area Served and Its Competitors

Table 87. Takeda Pharmaceutical Adult and Pediatric Vaccines Product Offered

Table 88. Takeda Pharmaceutical Main Business

Table 89. Takeda Pharmaceutical Adult and Pediatric Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 90. Takeda Pharmaceutical Latest Developments

Table 91. Bavarian Nordic Details, Company Type, Adult and Pediatric Vaccines Area Served and Its Competitors

Table 92. Bavarian Nordic Adult and Pediatric Vaccines Product Offered

Table 93. Bavarian Nordic Main Business

Table 94. Bavarian Nordic Adult and Pediatric Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 95. Bavarian Nordic Latest Developments

Table 96. LG Life Sciences Details, Company Type, Adult and Pediatric Vaccines Area Served and Its Competitors

Table 97. LG Life Sciences Adult and Pediatric Vaccines Product Offered

Table 98. LG Life Sciences Main Business

Table 99. LG Life Sciences Adult and Pediatric Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 100. LG Life Sciences Latest Developments

Table 101. Sinovac Biotech Details, Company Type, Adult and Pediatric Vaccines Area Served and Its Competitors

Table 102. Sinovac Biotech Adult and Pediatric Vaccines Product Offered

Table 103. Sinovac Biotech Adult and Pediatric Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 104. Sinovac Biotech Main Business

Table 105. Sinovac Biotech Latest Developments

List of Figures

Figure 1. Adult and Pediatric Vaccines Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Adult and Pediatric Vaccines Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Adult and Pediatric Vaccines Market Size Market Share by Type in 2021

Figure 7. Adult and Pediatric Vaccines in Hospitals

Figure 8. Global Adult and Pediatric Vaccines Market: Hospitals (2017-2022) & ($ Millions)

Figure 9. Adult and Pediatric Vaccines in Medical Care Centers

Figure 10. Global Adult and Pediatric Vaccines Market: Medical Care Centers (2017-2022) & ($ Millions)

Figure 11. Adult and Pediatric Vaccines in Others

Figure 12. Global Adult and Pediatric Vaccines Market: Others (2017-2022) & ($ Millions)

Figure 13. Global Adult and Pediatric Vaccines Market Size Market Share by Application in 2021

Figure 14. Global Adult and Pediatric Vaccines Revenue Market Share by Player in 2021

Figure 15. Global Adult and Pediatric Vaccines Market Size Market Share by Regions (2017-2022)

Figure 16. Americas Adult and Pediatric Vaccines Market Size 2017-2022 ($ Millions)

Figure 17. APAC Adult and Pediatric Vaccines Market Size 2017-2022 ($ Millions)

Figure 18. Europe Adult and Pediatric Vaccines Market Size 2017-2022 ($ Millions)

Figure 19. Middle East & Africa Adult and Pediatric Vaccines Market Size 2017-2022 ($ Millions)

Figure 20. Americas Adult and Pediatric Vaccines Value Market Share by Country in 2021

Figure 21. Americas Adult and Pediatric Vaccines Consumption Market Share by Type in 2021

Figure 22. Americas Adult and Pediatric Vaccines Market Size Market Share by Application in 2021

Figure 23. United States Adult and Pediatric Vaccines Market Size Growth 2017-2022 ($ Millions)

Figure 24. Canada Adult and Pediatric Vaccines Market Size Growth 2017-2022 ($ Millions)

Figure 25. Mexico Adult and Pediatric Vaccines Market Size Growth 2017-2022 ($ Millions)

Figure 26. Brazil Adult and Pediatric Vaccines Market Size Growth 2017-2022 ($ Millions)

Figure 27. APAC Adult and Pediatric Vaccines Market Size Market Share by Region in 2021

Figure 28. APAC Adult and Pediatric Vaccines Market Size Market Share by Application in 2021

Figure 29. China Adult and Pediatric Vaccines Market Size Growth 2017-2022 ($ Millions)

Figure 30. Japan Adult and Pediatric Vaccines Market Size Growth 2017-2022 ($ Millions)

Figure 31. Korea Adult and Pediatric Vaccines Market Size Growth 2017-2022 ($ Millions)

Figure 32. Southeast Asia Adult and Pediatric Vaccines Market Size Growth 2017-2022 ($ Millions)

Figure 33. India Adult and Pediatric Vaccines Market Size Growth 2017-2022 ($ Millions)

Figure 34. Australia Adult and Pediatric Vaccines Market Size Growth 2017-2022 ($ Millions)

Figure 35. Europe Adult and Pediatric Vaccines Market Size Market Share by Country in 2021

Figure 36. Europe Adult and Pediatric Vaccines Market Size Market Share by Type in 2021

Figure 37. Europe Adult and Pediatric Vaccines Market Size Market Share by Application in 2021

Figure 38. Germany Adult and Pediatric Vaccines Market Size Growth 2017-2022 ($ Millions)

Figure 39. France Adult and Pediatric Vaccines Market Size Growth 2017-2022 ($ Millions)

Figure 40. UK Adult and Pediatric Vaccines Market Size Growth 2017-2022 ($ Millions)

Figure 41. Italy Adult and Pediatric Vaccines Market Size Growth 2017-2022 ($ Millions)

Figure 42. Russia Adult and Pediatric Vaccines Market Size Growth 2017-2022 ($ Millions)

Figure 43. Middle East & Africa Adult and Pediatric Vaccines Market Size Market Share by Region in 2021

Figure 44. Middle East & Africa Adult and Pediatric Vaccines Market Size Market Share by Type in 2021

Figure 45. Middle East & Africa Adult and Pediatric Vaccines Market Size Market Share by Application in 2021

Figure 46. Egypt Adult and Pediatric Vaccines Market Size Growth 2017-2022 ($ Millions)

Figure 47. South Africa Adult and Pediatric Vaccines Market Size Growth 2017-2022 ($ Millions)

Figure 48. Israel Adult and Pediatric Vaccines Market Size Growth 2017-2022 ($ Millions)

Figure 49. Turkey Adult and Pediatric Vaccines Market Size Growth 2017-2022 ($ Millions)

Figure 50. GCC Country Adult and Pediatric Vaccines Market Size Growth 2017-2022 ($ Millions)

Figure 51. Americas Adult and Pediatric Vaccines Market Size 2023-2028 ($ Millions)

Figure 52. APAC Adult and Pediatric Vaccines Market Size 2023-2028 ($ Millions)

Figure 53. Europe Adult and Pediatric Vaccines Market Size 2023-2028 ($ Millions)

Figure 54. Middle East & Africa Adult and Pediatric Vaccines Market Size 2023-2028 ($ Millions)

Figure 55. United States Adult and Pediatric Vaccines Market Size 2023-2028 ($ Millions)

Figure 56. Canada Adult and Pediatric Vaccines Market Size 2023-2028 ($ Millions)

Figure 57. Mexico Adult and Pediatric Vaccines Market Size 2023-2028 ($ Millions)

Figure 58. Brazil Adult and Pediatric Vaccines Market Size 2023-2028 ($ Millions)

Figure 59. China Adult and Pediatric Vaccines Market Size 2023-2028 ($ Millions)

Figure 60. Japan Adult and Pediatric Vaccines Market Size 2023-2028 ($ Millions)

Figure 61. Korea Adult and Pediatric Vaccines Market Size 2023-2028 ($ Millions)

Figure 62. Southeast Asia Adult and Pediatric Vaccines Market Size 2023-2028 ($ Millions)

Figure 63. India Adult and Pediatric Vaccines Market Size 2023-2028 ($ Millions)

Figure 64. Australia Adult and Pediatric Vaccines Market Size 2023-2028 ($ Millions)

Figure 65. Germany Adult and Pediatric Vaccines Market Size 2023-2028 ($ Millions)

Figure 66. France Adult and Pediatric Vaccines Market Size 2023-2028 ($ Millions)

Figure 67. UK Adult and Pediatric Vaccines Market Size 2023-2028 ($ Millions)

Figure 68. Italy Adult and Pediatric Vaccines Market Size 2023-2028 ($ Millions)

Figure 69. Russia Adult and Pediatric Vaccines Market Size 2023-2028 ($ Millions)

Figure 70. Spain Adult and Pediatric Vaccines Market Size 2023-2028 ($ Millions)

Figure 71. Egypt Adult and Pediatric Vaccines Market Size 2023-2028 ($ Millions)

Figure 72. South Africa Adult and Pediatric Vaccines Market Size 2023-2028 ($ Millions)

Figure 73. Israel Adult and Pediatric Vaccines Market Size 2023-2028 ($ Millions)

Figure 74. Turkey Adult and Pediatric Vaccines Market Size 2023-2028 ($ Millions)

Figure 75. GCC Countries Adult and Pediatric Vaccines Market Size 2023-2028 ($ Millions)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390